Emerald Mutual Fund Advisers Trust 89bio, Inc. Transaction History
Emerald Mutual Fund Advisers Trust
- $1.75 Billion
- Q3 2025
A detailed history of Emerald Mutual Fund Advisers Trust transactions in 89bio, Inc. stock. As of the latest transaction made, Emerald Mutual Fund Advisers Trust holds 512,051 shares of ETNB stock, worth $7.6 Million. This represents 0.43% of its overall portfolio holdings.
Number of Shares
512,051
Previous 1,145,813
55.31%
Holding current value
$7.6 Million
Previous $11.3 Million
33.2%
% of portfolio
0.43%
Previous 0.77%
Shares
3 transactions
Others Institutions Holding ETNB
# of Institutions
235Shares Held
156MCall Options Held
774KPut Options Held
6.48M-
Ra Capital Management, L.P. Boston, MA19.9MShares$295 Million5.01% of portfolio
-
Pentwater Capital Management LP Naples, FL11.8MShares$174 Million1.08% of portfolio
-
Deep Track Capital, LP Greenwich, CT9.36MShares$139 Million4.33% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA9.1MShares$135 Million0.22% of portfolio
-
Suvretta Capital Management, LLC New York, NY8.28MShares$123 Million3.65% of portfolio
About 89bio, Inc.
- Ticker ETNB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,484,500
- Market Cap $690M
- Description
- 89bio, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. Its lead product candidate is pegozafermin, a glycoPEGylated analog of fibroblast growth factor 21 for the treatment of nonalcoholic steatohepatitis. The company also int...